Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.

Astrocytic brain tumors are the most frequent primary brain tumors. Treatment with radio- and chemotherapy has increased survival making prognostic biomarkers increasingly important. The aim of the present study was to investigate the expression and prognostic value of transferrin receptor-1 (TfR1)...

Full description

Saved in:
Bibliographic Details
Main Authors: Ann Mari Rosager, Mia D Sørensen, Rikke H Dahlrot, Steinbjørn Hansen, David L Schonberg, Jeremy N Rich, Justin D Lathia, Bjarne W Kristensen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182954&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595710649827328
author Ann Mari Rosager
Mia D Sørensen
Rikke H Dahlrot
Steinbjørn Hansen
David L Schonberg
Jeremy N Rich
Justin D Lathia
Bjarne W Kristensen
author_facet Ann Mari Rosager
Mia D Sørensen
Rikke H Dahlrot
Steinbjørn Hansen
David L Schonberg
Jeremy N Rich
Justin D Lathia
Bjarne W Kristensen
author_sort Ann Mari Rosager
collection DOAJ
description Astrocytic brain tumors are the most frequent primary brain tumors. Treatment with radio- and chemotherapy has increased survival making prognostic biomarkers increasingly important. The aim of the present study was to investigate the expression and prognostic value of transferrin receptor-1 (TfR1) as well as ferritin heavy (FTH) and light (FTL) chain in astrocytic brain tumors. A cohort of 111 astrocytic brain tumors (grade II-IV) was stained immunohistochemically with antibodies against TfR1, FTH, and FTL and scored semi-quantitatively. Double-immunofluorescence stainings were established to determine the phenotype of cells expressing these markers. We found that TfR1, FTH, and FTL were expressed by tumor cells in all grades. TfR1 increased with grade (p<0.001), but was not associated with prognosis in the individual grades. FTH and FTL were expressed by tumor cells and cells with microglial/macrophage morphology. Neither FTH nor FTL increased with malignancy grade, but low FTH expression by both tumor cells (p = 0.03) and microglia/macrophages (p = 0.01) correlated with shorter survival in patients anaplastic astrocytoma. FTL-positive microglia/macrophages were frequent in glioblastomas, and high FTL levels correlated with shorter survival in the whole cohort (p = 0.01) and in patients with anaplastic astrocytoma (p = 0.02). Double-immunofluorescence showed that TfR1, FTH, and FTL were co-expressed to a limited extent with the stem cell-related marker CD133. FTH and FTL were also co-expressed by IBA-1-positive microglia/macrophages. In conclusion, TfR1 was highly expressed in glioblastomas and associated with shorter survival in the whole cohort, but not in the individual malignancy grades. Low levels of FTH-positive tumor cells and microglia/macrophages were associated with poor survival in anaplastic astrocytomas, while high amounts of FTL-positive microglia/macrophages had a negative prognostic value. The results suggest that regulation of the iron metabolism in astrocytic brain tumors is complex involving both autocrine and paracrine signaling.
format Article
id doaj-art-c341d9379b374fc09fe174666de7839f
institution Kabale University
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-c341d9379b374fc09fe174666de7839f2025-01-18T05:31:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018295410.1371/journal.pone.0182954Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.Ann Mari RosagerMia D SørensenRikke H DahlrotSteinbjørn HansenDavid L SchonbergJeremy N RichJustin D LathiaBjarne W KristensenAstrocytic brain tumors are the most frequent primary brain tumors. Treatment with radio- and chemotherapy has increased survival making prognostic biomarkers increasingly important. The aim of the present study was to investigate the expression and prognostic value of transferrin receptor-1 (TfR1) as well as ferritin heavy (FTH) and light (FTL) chain in astrocytic brain tumors. A cohort of 111 astrocytic brain tumors (grade II-IV) was stained immunohistochemically with antibodies against TfR1, FTH, and FTL and scored semi-quantitatively. Double-immunofluorescence stainings were established to determine the phenotype of cells expressing these markers. We found that TfR1, FTH, and FTL were expressed by tumor cells in all grades. TfR1 increased with grade (p<0.001), but was not associated with prognosis in the individual grades. FTH and FTL were expressed by tumor cells and cells with microglial/macrophage morphology. Neither FTH nor FTL increased with malignancy grade, but low FTH expression by both tumor cells (p = 0.03) and microglia/macrophages (p = 0.01) correlated with shorter survival in patients anaplastic astrocytoma. FTL-positive microglia/macrophages were frequent in glioblastomas, and high FTL levels correlated with shorter survival in the whole cohort (p = 0.01) and in patients with anaplastic astrocytoma (p = 0.02). Double-immunofluorescence showed that TfR1, FTH, and FTL were co-expressed to a limited extent with the stem cell-related marker CD133. FTH and FTL were also co-expressed by IBA-1-positive microglia/macrophages. In conclusion, TfR1 was highly expressed in glioblastomas and associated with shorter survival in the whole cohort, but not in the individual malignancy grades. Low levels of FTH-positive tumor cells and microglia/macrophages were associated with poor survival in anaplastic astrocytomas, while high amounts of FTL-positive microglia/macrophages had a negative prognostic value. The results suggest that regulation of the iron metabolism in astrocytic brain tumors is complex involving both autocrine and paracrine signaling.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182954&type=printable
spellingShingle Ann Mari Rosager
Mia D Sørensen
Rikke H Dahlrot
Steinbjørn Hansen
David L Schonberg
Jeremy N Rich
Justin D Lathia
Bjarne W Kristensen
Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
PLoS ONE
title Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
title_full Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
title_fullStr Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
title_full_unstemmed Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
title_short Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
title_sort transferrin receptor 1 and ferritin heavy and light chains in astrocytic brain tumors expression and prognostic value
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182954&type=printable
work_keys_str_mv AT annmarirosager transferrinreceptor1andferritinheavyandlightchainsinastrocyticbraintumorsexpressionandprognosticvalue
AT miadsørensen transferrinreceptor1andferritinheavyandlightchainsinastrocyticbraintumorsexpressionandprognosticvalue
AT rikkehdahlrot transferrinreceptor1andferritinheavyandlightchainsinastrocyticbraintumorsexpressionandprognosticvalue
AT steinbjørnhansen transferrinreceptor1andferritinheavyandlightchainsinastrocyticbraintumorsexpressionandprognosticvalue
AT davidlschonberg transferrinreceptor1andferritinheavyandlightchainsinastrocyticbraintumorsexpressionandprognosticvalue
AT jeremynrich transferrinreceptor1andferritinheavyandlightchainsinastrocyticbraintumorsexpressionandprognosticvalue
AT justindlathia transferrinreceptor1andferritinheavyandlightchainsinastrocyticbraintumorsexpressionandprognosticvalue
AT bjarnewkristensen transferrinreceptor1andferritinheavyandlightchainsinastrocyticbraintumorsexpressionandprognosticvalue